Intron 4 VNTR polymorphism of eNOS gene is protective for cardiac syndrome X

Journal of Investigative Medicine

Volumn 58, Issue 1, 2010, Pages 23-27

  Sinici, Incilay ^a   Atalar, Enver ^a   Kepez, Alper ^a   Hayran, Mutlu ^a   Aksoyek, Serdar ^a   Tokgozoglu, Lale ^a   Ozmen, Ferhan ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Cardiac syndrome X; eNOS polymorphism; Intron 4; Microvascular ischemia; VNTR

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADULT; AGED; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CONTROLLED STUDY; EXON; FEMALE; GENE FREQUENCY; GENOTYPE; HEART PROTECTION; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION DISTRIBUTION; PROMOTER REGION; RESTRICTION MAPPING; SINGLE NUCLEOTIDE POLYMORPHISM; SYNDROME X; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; AGED; FEMALE; HUMANS; INTRONS; MALE; MICROVASCULAR ANGINA; MIDDLE AGED; MINISATELLITE REPEATS; NITRIC OXIDE SYNTHASE TYPE III;

EID: 74249114345     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.2310/JIM.0b013e3181c6197f     Document Type: Article

References (32)

1. Kaski JC, Russo G. Cardiac syndrome X: an overview. Hosp Pract (Minneap). 2000;35:75-76, 79-82, 85-88 passim.
2. Hurst T, Olson TH, Olson LE, et al. Cardiac syndrome X and endothelial dysfunction: new concepts in prognosis and treatment. Am J Med. 2006;119:560-566.
3. Egashira K, Inou T, Hirooka Y, et al. Evidence of impaired endothelium dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N Engl J Med. 1993;328:1659-1664.
4. Li JJ, Li YS, Zhang Y, et al. Inflammation: a possible pathogenic link to cardiac syndrome X. Med Hypotheses. 2006;66:87-91.
5. Monti LD, Piatti PM. Role of endothelial dysfunction and insulin resistance in angina pectoris and normal coronary angiogram. Herz. 2005;30:48-54.
6. Kaski JC. Cardiac syndrome X in women: the role of oestrogen deficiency. Heart. 2006;92:5-9.
7. Panting JR, Gatehouse PD, Yang GZ, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med. 2002;346:1948-1953.
8. Kolasińska-Kloch W, Lesniak W, Kiec-Wilk B, et al. Biochemical parameters of endothelial dysfunction in cardiological syndrome X. Scand J Clin Lab Invest. 2002;62:7-13.
9. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004;109(23 Suppl 1):III27-III32.
10. Buffon A, Rigattieri S, Santini SA, et al. Myocardial ischemia-reperfusion damage after pacing-induced tachycardia in patients with cardiac syndrome X. Am J Physiol Heart Circ Physiol. 2000;279:H2627-2633.
11. Galassi AR, Crea F, Araujo LI, et al. Comparison of myocardial blood flow in syndrome X and one-vessel coronary artery disease. Am J Cardiol. 1993;72:134-142.
12. Napoli C, de Nigris F, Williams-Ignarro S, et al. Nitric oxide and atherosclerosis: an update. Nitric Oxide. 2006;15:265-279.
13. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002-2012.
14. Davidson S. Research suggests importance of haplotypes over SNPs. Nat Biotechnol. 2000;18:1134-1135.
15. Casas JP, Cavalleri GL, Bautista LE, et al. Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review. Am J Epidemiol. 2006;164:921-935.
16. Kolasińska-Kloch W, Jabrocka A, Kieć-Wilk B, et al. Relations between endothelial nitric oxide synthase and angiotensin-converting gene polymorphisms and certain biochemical parameters in patients with cardiac syndrome X. Przegl Lek. 2004;61:743-746.
17. Tsukada T, Yokoyama K, Arai T, et al. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun. 1998;245:190-193.
18. Tanus-Santos JE, Desai M, Deak LR, et al. Effects of endothelial nitric oxide synthase gene polymorphisms on platelet function, nitric oxide release, and interactions with estradiol. Pharmacogenetics. 2002;12:407-413.
19. Chauhan A, Mullins PA, Taylor G, et al. Both endothelium-dependent and endothelium-independent function is impaired in patients with angina pectoris and normal coronary angiograms. Eur Heart J. 1997;18:60-68.
20. Lanza GA, Lüscher TF, Pasceri V, et al. Effects of atrial pacing on arterial and coronary sinus endothelin-1 levels in syndrome X. Am J Cardiol. 1999;84:1187-1191.
21. Wang J, Donald D, Wang XL. Haplotype-specific effects on endothelial NO synthase promoter efficiency: modifiable by cigarette smoking. Arterioscler Thromb Vasc Biol. 2002;22:1-4.
22. Kim JU, Chang HK, Lee SS, et al. Endothelial nitric oxide synthase gene polymorphisms in Behcet's disease and rheumatic diseases with vasculitis. Ann Rheum Dis. 2003;62:1083-1087.
23. Nakayama M, Yasue H, Yoshimura M, et al. T-786-→C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation. 1999;99:2864-2870.
24. Uzu T, Kimura G, Yamauchi A, et al. Enhanced sodium sensitivity and disturbed circadian rhythm of blood pressure in essential hypertension. J Hypertens. 2006;24:1627-1632.
25. Berdeli A, Sekuri C, Sirri Cam F, et al. Association between the eNOS (Glu298Asp) and the RAS genes polymorphisms and premature coronary artery diseases in a Turkish population. Clin Chim Acta. 2005;351:87-94.
26. Afrasyap L, Ozturk G. NO level and endothelial NO synthase gene polymorphism (Glu298Asp) in the patients with coronary artery disease from the Turkish population. Acta Biochim Biophys Sin (Shanghai). 2004;36:661-666.
27. Jaramillo PC, Muñoz MA, Lanas MC, et al. Endothelial nitric oxide synthase G894T gene polymorphism in Chilean subjects with coronary artery disease and controls. Clin Chim Acta. 2006;371:102-106.
28. Kato N, Sugiyama T, Morita H, et al. Lack of evidence for association between the endothelial nitric oxide synthase gene and hypertension. Hypertension. 1999;33:933-936.
29. Poirier O, Mao C, Mallet C, et al. Polymorphism of the endothelial nitric oxide synthase gene no consistent association with myocardial infarction in the ECTIM study. Eur J Clin Invest. 1999;29:284-290.
30. Rankinen T, Rice T, Pérusse L, et al. NOS3 Glu298Asp genotype and blood pressure response to endurance training, the heritage family study. Hypertension. 2000;36:885-889.
31. Wattanapitayakul SK, Mihm MJ, Young AP, et al. Therapeutic implications of human endothelial nitric oxide synthase gene polymorphism. Trends Pharmacol Sci. 2001;22:361-368.
32. Tesauro M, Thomspon WC, Rogliani P, et al. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci U S A. 2000;97:2832-2835.